Optinose

Wall Street firms have given rave reviews for OptiNose Inc (NASDAQ: OPTN), which IPO-ed recently. BMO Capital Markets was no exception, assigning its top rating to shares of the company. The Analyst BMO issued its initiation note on OptiNose on Tuesday, with Gary Nachman being the lead analyst...

If you’ve rapaciously bought stock in the proliferating pharma space, you’ve had a good year in initial public offerings. But this isn’t your week. Investors looking for something outside the norm have a few unique options among market newcomers. Here are the firms preparing for...